Diabetes and Your Eyes
Benfotiamine And Diabetic Retinopathy
By
Zach Malott
Damage from diabetes can occur in different areas of the eye. It
can occur to the cornea, nerves controlling the muscles of the eye,
the lens, optic nerve and retina. The retina is the complication
that most people and medical professionals think of first in terms
of diabetic complications.
Diabetic retinopathy is simply damage to the light sensitive
retina. This damage is brought about by hyperglycemia, the medical
term for high blood sugar. Retinopathy is directly responsible for
approximately 12,000 to 24,000 cases of legal blindness every year
in the USA alone. It is reported that there are over 200,000 cases
each year globally.
Diabetic complications are even more insidious than these numbers
because there are several other types of diabetic eye disease
created wholly or in part by high blood sugar in diabetics.
What Can Be Done To Prevent Eye Disease?
It stands to reason that the more informed a person is about a
particular situation the better equipped they will be to handle it.
Diabetic eye disease is just such a case in point. We need to think
of the whole person and not just the eyes when discussing diabetic
education because diabetic complications run from eye disease, heart
disease, nerve damage, kidney damage, etc. Although benfotiamine has
been found useful for all of the above, for the sake of this article
in terms of prevention, we will discuss diabetic eye disease in
terms of diabetic retinopathy.
Diabetic retinopathy is a disease that every diabetic faces the
possibility of suffering from somewhere in the course of their
disease. The better patients of diabetes are equipped to handle
their disease, the lower their risk that they will develop
retinopathy. If retinopathy does develop in a patient who is doing
all he/she can do to lessen the impact of blood sugar on their
bodies, the better chance that they can live productive lives
despite the complications and the slower such complications will
progress.
What Works Best?
Unfortunately, there are very few options that are showing much
promise for the diabetic in terms of diabetic complications.
Benfotiamine has been suggested recently to be a strong deterrent
against the development of diabetic retinopathy and also shown to
slow its progression significantly if it develops. It is showing
great promise in the arena of retinopathy, neuropathy and
heart/circulatory conditions brought about by excess sugar in the
cells.
Benfotiamine, a lipid soluble derivative of water soluble vitamin
B1 (thiamine), has been used for the past 12 years in Europe for the
treatment of neuropathy, retinopathy as well as heart and
circulatory conditions and has shown no adverse effects.
Much of the current research on benfotiamine can be discovered by
typing the term benfotiamine into a search engine such as google,
AOL, yahoo, etc.
Conclusion
Diabetic complications are a reality that must be an accepted
possibility for every diabetic. Diabetic education is highly
necessary so that the diabetic community is able to make informed
decisions as to their treatment and prevention methodologies. There
are few things that show great promise in preventing and/or helping
neuropathy, retinopathy, heart and circulatory problems brought
about by diabetes. Keeping blood sugar levels close to normal along
with adequate exercise in line with the abilities of each individual
has shown to help slow the onset of diabetic complications.
Benfotiamine is a nutritional supplement that has shown to be
helpful in Europe over the past 12 years in terms of diabetic
complications and is now available in the United States, and might
be worth the time to investigate further. How about for the diabetic
who faces the insidious nature of diabetic complications?
Zach Malott is CEO of Brentwood Health International, a
nutritional supplement company involved in distribution and
supplying wholesale, retail and end user
Article Source:
http://EzineArticles.com/?expert=Zach_Malott
Copyright DiabeticAdvisory.com | Help for Managing Diabetes Since 2006
| All Rights Reserved |